Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd / Fundamentals

    Income statement

    Net revenue
    €30.43M
    Cost of goods sold
    €7.19M
    Gross profit
    €23.24M
    SG&A expenses
    €13.15M
    R&D expenses
    €1.05M
    EBITDA
    €5.46M
    D&A
    €0.00
    EBIT
    €5.32M
    Interest expenses
    €35.40K
    EBT
    €5.42M
    Tax expenses
    €746.59K
    Net income
    €4.85M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    €3.07M
    Changes in working capital
    €0.00
    Operating cash flow
    €4.21M
    Capex
    €11.80M
    Other investing cash flow
    -€9.35M
    Net investing cash flow
    -€11.28M
    Total cash dividends paid
    -€2.40M
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    -€823.10K
    Net financing cash flow
    -€3.22M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€7.91M
    Cash at end of period
    €12.20M
    Free cash flow
    €16.01M

    Balance sheet

    Cash and cash equivalents
    €12.27M
    Cash and short-term investments
    €30.95M
    Total receivables
    €7.80M
    Inventory
    €3.13M
    Other current assets
    €1.58M
    Total current assets
    €43.46M
    Property, plant & equipment
    €60.38M
    Goodwill
    €3.64M
    Intangible assets
    €11.42M
    Long-term investments
    €0.00
    Other non-current assets
    €5.65M
    Total non-current assets
    €82.15M
    Total assets
    €125.61M
    Accounts payable
    €3.58M
    Short-term debt
    €1.19M
    Other current liabilities
    €2.74M
    Total current liabilities
    €8.40M
    Long-term debt
    €1.30K
    Deferred tax liabilities
    €588.49K
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €4.80M
    Total liabilities
    €13.20M
    Common stock
    €9.10M
    Retained earnings
    €47.21M
    Other equity
    €0.00
    Total equity
    €112.41M
    Total liabilities and shareholders' equity
    €125.61M

    Company information

    Market capitalization
    €254.84M
    Employees
    269
    Enterprise Value
    €2.16B

    Company ratios

    Gross margin
    76.4%
    EBITDA margin
    17.9%
    EBIT margin
    17.5%
    EBT margin
    17.8%
    Net margin
    15.9%
    ROE
    4.3%
    ROA
    3.9%
    Asset turnover
    24.2%
    FCF margin
    -24.9%
    FCF yield
    -3.0%
    Efficiency ratio
    82.1%
    Net sales per employee
    €113.12K
    Net income per employee
    €18.03K

    Notifications